Literature DB >> 19698078

APOBEC3B deletion and risk of HIV-1 acquisition.

Ping An1, Randall Johnson, John Phair, Gregory D Kirk, Xiao-Fang Yu, Sharyne Donfield, Susan Buchbinder, James J Goedert, Cheryl A Winkler.   

Abstract

The human APOBEC3 family of cytidine deaminases provides intrinsic immunity to retroviral infection. A naturally occurring 29.5-kb deletion removes the entire APOBEC3B gene. We examined the impact of the APOBEC3B gene deletion in >4000 individuals from 5 human immunodeficiency virus type 1 (HIV-1) natural history cohorts. The hemizygous genotype had no effect on either acquisition of HIV-1 infection or progression to AIDS. However, the homozygous deletion was significantly associated with unfavorable outcomes for HIV-1 acquisition (odds ratio, 7.37; P= .024), progression to AIDS (relative hazard, 4.01; P=. 03), and viral set point (P= .04). These findings suggest that the loss of APOBEC3B may increase host susceptibility to HIV-1 acquisition and progression to AIDS and warrant further study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19698078      PMCID: PMC3690486          DOI: 10.1086/605644

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.

Authors:  Hal P Bogerd; Heather L Wiegand; Brian P Doehle; Bryan R Cullen
Journal:  Virology       Date:  2007-04-16       Impact factor: 3.616

2.  Exact logistic regression: theory and examples.

Authors:  C R Mehta; N R Patel
Journal:  Stat Med       Date:  1995-10-15       Impact factor: 2.373

3.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

4.  Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.

Authors:  Yong-Hui Zheng; Dan Irwin; Takeshi Kurosu; Kenzo Tokunaga; Tetsutaro Sata; B Matija Peterlin
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  APOBEC3G genetic variants and their influence on the progression to AIDS.

Authors:  Ping An; Gabriela Bleiber; Priya Duggal; George Nelson; Margaret May; Bastien Mangeat; Irene Alobwede; Didier Trono; David Vlahov; Sharyne Donfield; James J Goedert; John Phair; Susan Buchbinder; Stephen J O'Brien; Amalio Telenti; Cheryl A Winkler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.

Authors:  Qin Yu; Darlene Chen; Renate König; Roberto Mariani; Derya Unutmaz; Nathaniel R Landau
Journal:  J Biol Chem       Date:  2004-10-04       Impact factor: 5.157

Review 7.  Human genes that limit AIDS.

Authors:  Stephen J O'Brien; George W Nelson
Journal:  Nat Genet       Date:  2004-06       Impact factor: 38.330

8.  Cytidine deamination of retroviral DNA by diverse APOBEC proteins.

Authors:  Kate N Bishop; Rebecca K Holmes; Ann M Sheehy; Nicholas O Davidson; Soo-Jin Cho; Michael H Malim
Journal:  Curr Biol       Date:  2004-08-10       Impact factor: 10.834

9.  Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals.

Authors:  Ping An; Priya Duggal; Li Hua Wang; Stephen J O'Brien; Sharyne Donfield; James J Goedert; John Phair; Susan Buchbinder; Gregory D Kirk; Cheryl A Winkler
Journal:  PLoS Genet       Date:  2007-01-26       Impact factor: 5.917

10.  Population stratification of a common APOBEC gene deletion polymorphism.

Authors:  Jeffrey M Kidd; Tera L Newman; Eray Tuzun; Rajinder Kaul; Evan E Eichler
Journal:  PLoS Genet       Date:  2007-04-20       Impact factor: 5.917

View more
  27 in total

1.  Accessory genes confer a high replication rate to virulent feline immunodeficiency virus.

Authors:  Ryan M Troyer; Jesse Thompson; John H Elder; Sue VandeWoude
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

2.  Relating CNVs to transcriptome data at fine resolution: assessment of the effect of variant size, type, and overlap with functional regions.

Authors:  Andreas Schlattl; Simon Anders; Sebastian M Waszak; Wolfgang Huber; Jan O Korbel
Journal:  Genome Res       Date:  2011-08-23       Impact factor: 9.043

3.  Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.

Authors:  In-Ja L Byeon; Chang-Hyeock Byeon; Tiyun Wu; Mithun Mitra; Dustin Singer; Judith G Levin; Angela M Gronenborn
Journal:  Biochemistry       Date:  2016-05-19       Impact factor: 3.162

Review 4.  Host genes associated with HIV/AIDS: advances in gene discovery.

Authors:  Ping An; Cheryl A Winkler
Journal:  Trends Genet       Date:  2010-02-10       Impact factor: 11.639

5.  A common deletion in the APOBEC3 genes and breast cancer risk.

Authors:  Jirong Long; Ryan J Delahanty; Guoliang Li; Yu-Tang Gao; Wei Lu; Qiuyin Cai; Yong-Bing Xiang; Chun Li; Bu-Tian Ji; Ying Zheng; Simak Ali; Xiao-Ou Shu; Wei Zheng
Journal:  J Natl Cancer Inst       Date:  2013-02-14       Impact factor: 13.506

6.  The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B.

Authors:  Vladimir Pak; Gisela Heidecker; Vinay K Pathak; David Derse
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

Review 7.  Immune mechanisms of HIV control.

Authors:  Lisa A Chakrabarti; Viviana Simon
Journal:  Curr Opin Immunol       Date:  2010-08       Impact factor: 7.486

8.  APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry.

Authors:  Dennis Xuan; Guoliang Li; Qiuyin Cai; Sandra Deming-Halverson; Martha J Shrubsole; Xiao-Ou Shu; Mark C Kelley; Wei Zheng; Jirong Long
Journal:  Carcinogenesis       Date:  2013-05-28       Impact factor: 4.944

Review 9.  Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics.

Authors:  John S Albin; Reuben S Harris
Journal:  Expert Rev Mol Med       Date:  2010-01-22       Impact factor: 5.600

10.  Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.

Authors:  Andrew E Armitage; Koen Deforche; John J Welch; Kristel Van Laethem; Ricardo Camacho; Andrew Rambaut; Astrid K N Iversen
Journal:  J Virol       Date:  2014-08-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.